REG News
Regency Centers Corporation
$73.04
+$1.27(+1.77%)
62
Overall
100
Value
18
Tech
68
Quality
Market Cap
$13.14B
Volume
1.69M
52W Range
$66.86 - $83.66
Target Price
$84.83
REG news: the latest Regency Centers Corporation headlines, press releases and market updates, newest first.
Latest REG News
- RemeGen Deploys Idle Funds Into RMB670 Million SPDB Wealth ProductsTipRanks HongKong Auto-Generated Newsdesk · Oct 14, 2026
- Aksa Akrilik details conversion of shares to tradable statusTipRanks Turkey Auto-Generated Newsdesk · Oct 12, 2026
- Bank of America Securities Sticks to Their Buy Rating for Regeneron (REGN)TipRanks Auto-Generated Intelligence Newsdesk · Oct 12, 2026
- Creactives Publishes Materials for October Shareholders’ MeetingTipRanks Italy Auto-Generated Newsdesk · Oct 9, 2026
- Regeneron Advances Pediatric Rare Disease Program With New Phase 3 Garetosmab StudyTipRanks Clinical-Trials-Auto-Generated Newsdesk · Oct 8, 2026
- Creactives Group convenes ordinary shareholders’ meeting for October 2026TipRanks Italy Auto-Generated Newsdesk · Oct 8, 2026
- Creactives Group Seeks Investor Visibility at NEXT GEMs Conference in MilanTipRanks Italy Auto-Generated Newsdesk · Oct 7, 2026
- BTIG Reaffirms Their Buy Rating on Regency Centers (REG)TipRanks Auto-Generated Intelligence Newsdesk · Oct 3, 2026
- Analysts Offer Insights on Healthcare Companies: Cigna (CI), Wave Life Sciences (WVE) and Regeneron (REGN)TipRanks Newsroom · Oct 2, 2026
- Analysts’ Top Healthcare Picks: Regeneron (REGN), Idexx Laboratories (IDXX)TipRanks Newsroom · Oct 2, 2026
- Barclays Sticks to Its Buy Rating for Regeneron (REGN)TipRanks Auto-Generated Intelligence Newsdesk · Oct 2, 2026
- Jefferies Sticks to Their Buy Rating for Regeneron (REGN)TipRanks Auto-Generated Intelligence Newsdesk · Oct 1, 2026
- Real-World Dupixent Data in Itchy Skin Disease: What Sanofi and Regeneron Investors Should WatchTipRanks Clinical-Trials-Auto-Generated Newsdesk · Oct 1, 2026
- Orège Publishes 2026 Half-Year Financial ReportTipRanks European Auto-Generated Newsdesk · Sep 30, 2026
- Regeneron (REGN) Receives a Hold from BernsteinTipRanks Auto-Generated Intelligence Newsdesk · Sep 26, 2026
- Analysts Are Bullish on Top Healthcare Stocks: Agilent (A), Regeneron (REGN)TipRanks Newsroom · Sep 26, 2026
- Regeneron Steps Into Obesity Drug Race With New Phase 1 StudyTipRanks Clinical-Trials-Auto-Generated Newsdesk · Sep 25, 2026
- Eregli Steel Shares Converted to Tradable Stock on Turkish ExchangeTipRanks Turkey Auto-Generated Newsdesk · Sep 24, 2026
- RBC Capital Sticks to Their Hold Rating for Regeneron (REGN)TipRanks Auto-Generated Intelligence Newsdesk · Sep 24, 2026
- Creactives boosts recurring revenue and profitability as international and partner business expandTipRanks Italy Auto-Generated Newsdesk · Sep 23, 2026
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | REG | $73.04 | +1.8% | 1.69M |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |
Get Regency Centers Corporation Data in Excel
Stream real-time data directly to your spreadsheets
BUY NOW